GW PHARMACEUTICALS PLC Depreciation
GW PHARMACEUTICALS PLC reported Depreciation of $2.90 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2021-05-03
- GW PHARMACEUTICALS PLC depreciation for the quarter ending 2021-03-31 was $2.90M, a 38.10% increase year-over-year.
- GW PHARMACEUTICALS PLC depreciation for the quarter ending 2020-12-31 was $2.80M, a 55.56% increase year-over-year.
- GW PHARMACEUTICALS PLC depreciation for the quarter ending 2020-09-30 was $2.80M, a 40.00% increase year-over-year.
- GW PHARMACEUTICALS PLC depreciation for the quarter ending 2020-06-30 was $2.20M, a 4.76% increase year-over-year.
- GW PHARMACEUTICALS PLC depreciation for fiscal 2020 was $9.90M, a 23.75% increase from fiscal 2019.
- GW PHARMACEUTICALS PLC depreciation for fiscal 2019 was $8.00M.
- GW PHARMACEUTICALS PLC depreciation for fiscal 2018 was $8.50M, a 21.43% increase from fiscal 2017.
- GW PHARMACEUTICALS PLC depreciation for fiscal 2017 was $7.00M, a 37.25% increase from fiscal 2016.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2021-03-31 | $2.90M 10-Q · filed 2021-05-03 | $5.70M derived: sum of 2 quarters · filed 2021-05-03 | $8.50M derived: sum of 3 quarters · filed 2021-05-03 | $10.70M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $5.60M derived: sum of 2 quarters · filed 2021-02-26 | $7.80M derived: sum of 3 quarters · filed 2021-02-26 | $9.90M 10-K · filed 2021-02-26 |
| 2020-09-30 | $2.80M 10-Q · filed 2020-11-05 | $5.00M derived: sum of 2 quarters · filed 2020-11-05 | $7.10M 10-Q · filed 2020-11-05 | $8.90M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $2.20M 10-Q · filed 2020-08-07 | $4.30M 10-Q · filed 2020-08-07 | $6.10M derived: sum of 3 quarters · filed 2021-05-03 | $8.10M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $2.10M 10-Q · filed 2021-05-03 | $3.90M derived: sum of 2 quarters · filed 2021-05-03 | $5.90M derived: sum of 3 quarters · filed 2021-05-03 | $8.00M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $3.80M derived: sum of 2 quarters · filed 2021-02-26 | $5.90M derived: sum of 3 quarters · filed 2021-02-26 | $8.00M 10-K · filed 2021-02-26 |
| 2019-09-30 | $2.00M 10-Q · filed 2020-11-05 | $4.10M derived: sum of 2 quarters · filed 2020-11-05 | $6.20M 10-Q · filed 2020-11-05 | $8.40M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $2.10M 10-Q · filed 2020-08-07 | $4.20M 10-Q · filed 2020-08-07 | $6.40M derived: sum of 3 quarters · filed 2021-02-26 | $8.50M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $2.10M 10-Q · filed 2020-05-11 | $4.30M derived: sum of 2 quarters · filed 2021-02-26 | $6.40M derived: sum of 3 quarters · filed 2021-02-26 | $8.60M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $2.20M 10-K · filed 2021-02-26 | $4.30M derived: sum of 2 quarters · filed 2021-02-26 | $6.50M derived: sum of 3 quarters · filed 2021-02-26 | $8.70M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | $2.10M 10-Q · filed 2019-11-06 | $4.30M derived: sum of 2 quarters · filed 2019-11-06 | $6.50M 10-Q · filed 2019-11-06 | $8.50M 10-K · filed 2021-02-26 |
| 2018-06-30 | $2.20M 10-Q · filed 2019-08-07 | $4.40M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $2.20M 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | $7.00M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | $5.10M 10-KT · filed 2019-02-28 |